Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study
Article in Journal of Neurology (September 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Journal of Neurology (September 2023)
Article in Multiple Sclerosis and Related Disorders (December 2022)
Article in CNS & Neurological Disorders - Drug Targets (January 2022)